<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04748887</url>
  </required_header>
  <id_info>
    <org_study_id>oxidative stress</org_study_id>
    <nct_id>NCT04748887</nct_id>
  </id_info>
  <brief_title>Oxidative Stress Markers in COPD</brief_title>
  <official_title>Chronic Obstructive Pulmonary Disease in Non Smokers:Role of Oxidative Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:Striking feature of Chronic obstructive pulmonary disease (COPD) is its inability&#xD;
      to resolve after cigarette smoke exposure has ended, which has contributed to the possibility&#xD;
      that the disease could also be driven by other endogenous causes, such as autoimmunity or&#xD;
      chronic infection . Many of the pathogenetic pathways involved in COPD and its development&#xD;
      tend to be driven by oxidative stress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>oxidative stress markers in non smokers COPD compared to healthy control</measure>
    <time_frame>1month</time_frame>
    <description>markers of oxidative stress , Superoxide Dismutase (SOD) and Malondialdehyde (MDA) by ( ELISA Kit SinoGeneClon Biotech Co.,Ltd Catalog No : SG- 10188) .</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">70</enrollment>
  <condition>Role of Oxidative Stress in COPD</condition>
  <arm_group>
    <arm_group_label>nonsmokers copd cases ,</arm_group_label>
    <description>Fourty subjects of COPD who are non-smokers or stopped smoking for more than 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non smokers healthy control</arm_group_label>
    <description>Thirty subjects of non smokers healthy control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxidative stess markers</intervention_name>
    <description>markers of oxidative stress , Superoxide Dismutase (SOD) and Malondialdehyde (MDA) by ( ELISA Kit SinoGeneClon Biotech Co.,Ltd Catalog No : SG- 10188) .</description>
    <arm_group_label>non smokers healthy control</arm_group_label>
    <arm_group_label>nonsmokers copd cases ,</arm_group_label>
    <other_name>Superoxide Dismutase (SOD) and Malondialdehyde (MDA)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Forty subjects of COPD who are non-smokers or stopped smoking for more than 6 months Based&#xD;
        on the Global Initiative for Chronic Obstructive Lung Disease guidelines, COPD was&#xD;
        diagnosed.9 2- Thirty subjects of non smokers healthy control&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1-Forty subjects of COPD who are non-smokers or stopped smoking for more than 6 months&#xD;
             Based on the Global Initiative for Chronic Obstructive Lung Disease guidelines, COPD&#xD;
             was diagnosed.9 2- Thirty subjects of non smokers healthy control&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients of:&#xD;
&#xD;
               1. Acute exacerbation, at the time of the study, of COPD.&#xD;
&#xD;
               2. Any obvious abnormal lung parenchymal lesions.&#xD;
&#xD;
               3. Lung cancer.&#xD;
&#xD;
               4. Congestive heart failure.&#xD;
&#xD;
               5. current smokers&#xD;
&#xD;
               6. Drugs e.g anti-inflammatory , steroids ,analgesics, insulin , antineoplastic,&#xD;
                  antipsychotic drugs in the previous 2 weeks before the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>zainab H Saeed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD chest diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minia University Hospital</name>
      <address>
        <city>Multiple Locations</city>
        <state>Minia</state>
        <zip>61691</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>zainab hassan saeed</investigator_full_name>
    <investigator_title>principle investigator ,faculty of medicine,department of chest diseases,Minia University</investigator_title>
  </responsible_party>
  <keyword>COPD , oxidative stress, Superoxide Dismutase</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Superoxide Dismutase</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

